AMPK Cancer Research Results
AMPK, adenosine monophosphate-activated protein kinase: Click to Expand ⟱
| Source: |
| Type: |
AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways.
-Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation.
AMPK activators:
-metformin or AICAR
-Resveratrol: activate AMPK indirectly
-Berberine
-Quercetin: may stimulate AMPK
-EGCG: thought to activate AMPK
-Curcumin: may activate AMPK
-Ginsenosides: Some ginsenosides have been associated with AMPK activation
-Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models.
-Alpha-Lipoic Acid (ALA): associated with AMPK activation
|
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
ESCC, |
TE1 |
|
|
|
- |
vitro+vivo, |
ESCC, |
KYSE-510 |
|
|
|
- |
in-vitro, |
Nor, |
Het-1A |
|
|
|
TumCP↓, LC3‑Ⅱ/LC3‑Ⅰ↑, p62↓, p‑AMPK↑, mTOR↓, TumAuto↑, NCOA4↑, MDA↑, Iron↑, TumW↓, TumVol↓, ATG5↑, ATG7↑, TfR1/CD71↓, FTH1↓, ROS↑, Iron↑, Ferroptosis↑, *toxicity↓,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
TumCG↑, Glycolysis↓, ROS↑, CSCs↓, selectivity↑, LC3B-II↑, MMP↓, mitResp↓, ATP↓, OCR↓, NAD↓, p‑AMPK↑, GlucoseCon↓, lactateProd↓, HK2↓, PFK↓, LDHA↓, eff↓, mTOR↓, ECAR↓, ALDH↓, CD44↓, CD24↓,
NRF2↑, COX2↓, IL6↓, IL8↓, IL1↓, iNOS↓, MPO↓, TNF-α↓, VEGF↓, Hif1a↓, p‑AMPK↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
AntiCan↓, *neuroP↑, *cardioP↑, *hepatoP↑, *RenoP↑, TumCCA↑, CDK4↓, cycD1/CCND1↓, cycE/CCNE↑, BAX↑, Bcl-2↓, VEGF↓, Hif1a↓, cMyc↓, NF-kB↓, ROS↑, BNIP3↑, *neuroP↑, *cognitive↑, *NO↓, *iNOS↓, *COX2↓, *PGE2↓, *NRF2↑, *p‑AMPK↑, *Ferroptosis↓, *lipid-P↓, *ALAT↓, *AST↓, *Fas↓, *BAX↓, *Apoptosis↓,
*ECAR↑, *OCR↓, *p‑AMPK↑, *p‑ACC↑, *Glycolysis↑, *lipidDe↓, *SREBP1↓, *FAO↑, *HK2↑, *PKM2↑, *LDHA↑, *PDKs↓, *ACC↓,
*α-SMA↓, *TGF-β1↓, *IL10↑, *p‑AMPK↑, *p‑mTOR↓, *P70S6K↓, *cardioP↑,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
tumCV↓, TumCP↓, TumCMig↓, Casp↑, TumAuto↑, LC3B-II↑, p‑AMPK↑, mTOR↓, BMI1↓, ROS↑, eff↓,
TumCMig↓, TumCI↓, MMP9↓, p‑AMPK↑, SIRT1↑, NF-kB↓, p‑IκB↑,
| - |
in-vitro, |
CRC, |
HCT116 |
|
|
|
- |
in-vitro, |
CRC, |
HCT8 |
|
|
|
- |
in-vitro, |
CRC, |
SW480 |
|
|
|
- |
in-vitro, |
CRC, |
SW-620 |
|
|
|
p‑AMPK↑, p‑ACC-α↑, NBR2↑, p‑S6K↓, mTOR↓,
| - |
in-vitro, |
BC, |
BT474 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
Nor, |
MCF10 |
|
|
|
Hif1a↓, GLUT1↓, LDH↓, GlucoseCon↓, lactateProd↓, ATP↓, p‑AMPK↑, ECAR↓, OCR↓, *toxicity↓,
*glucose↓, ROS↑, LC3B↑, p62↓, p‑mTOR↓, p‑AMPK↑,
ROS↑, p‑AMPK↑, mTOR↓, FAK↓, Smo↓, Gli1↓, HH↓, TumCMig↓, TumCI↓, NOTCH↓, JAK↓, STAT↓, Bcl-2↓, Bcl-xL↓, BAX↑, Casp9↑,
Apoptosis↑, DNAdam↑, Casp3↑, cl‑PARP↑, p‑AMPK↑, Bcl-2↓, P53↑, BAX↑, Cyt‑c↑, TumCMig↓, TumCI↓,
CAFs/TAFs↝, p‑AMPK↑, PHDs↑, Hif1a↓, TumCI↓,
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
GlucoseCon↓, TumCG↓, HK2↓, p‑AMPK↑, TXNIP↓, *toxicity↓,
| - |
in-vitro, |
Ovarian, |
SKOV3 |
|
|
|
TumCMig↓, TumCI↓, MDA↑, ROS↑, BAX↑, Casp3↑, Bcl-2↓, SREBP1↓, FASN↓, AMPK↓, p‑AMPK↑, p‑P53↑, p‑TSC2↑, p‑Akt↓, p‑mTOR↓, p‑S6K↓, p‑4E-BP1↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
ChemoSideEff↓, ChemoSen↑, antiOx↑, MMP2↓, MMP9↓, p‑AMPK↑, DNMTs↓, tumCV↓, COX2↓, E-cadherin↑, Vim↓, N-cadherin↓, EMT↓, Casp3↑, Casp9↓, ROS↓, GSH↑, ERK↓, Akt↓, ROS↓, NF-kB↓, p‑IκB↓, p50↓, p65↓, neuroP↑, Dose↝,
TumCP↓, Apoptosis↑, TumCCA↑, CycB/CCNB1↑, P21↑, p‑H3↑, p‑AMPK↑, eff↓, MMP↓, Cyt‑c↑, ROS↑, eff↓,
| - |
in-vivo, |
Alcohol, |
NA |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
*p‑AMPK↑, *SIRT1↑, *NRF2↑, *CYP2E1↓, *lipoGen↓, *ROS↓, *Inflam↓,
Showing Research Papers: 1 to 19 of 19
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 19
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 1, Ferroptosis↑, 1, GSH↑, 1, Iron↑, 2, MDA↑, 2, MPO↓, 1, NRF2↑, 1, ROS↓, 2, ROS↑, 8,
Metal & Cofactor Biology ⓘ
FTH1↓, 1, NCOA4↑, 1, TfR1/CD71↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↓, 2, mitResp↓, 1, MMP↓, 2, OCR↓, 2,
Core Metabolism/Glycolysis ⓘ
p‑ACC-α↑, 1, AMPK↓, 1, p‑AMPK↑, 15, ATG7↑, 1, cMyc↓, 1, ECAR↓, 2, FASN↓, 1, GlucoseCon↓, 3, Glycolysis↓, 1, HK2↓, 2, lactateProd↓, 2, LDH↓, 1, LDHA↓, 1, NAD↓, 1, PFK↓, 1, p‑S6K↓, 2, SIRT1↑, 1, SREBP1↓, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, Apoptosis↑, 2, BAX↑, 4, Bcl-2↓, 4, Bcl-xL↓, 1, Casp↑, 1, Casp3↑, 3, Casp9↓, 1, Casp9↑, 1, Cyt‑c↑, 2, Ferroptosis↑, 1, iNOS↓, 1,
Kinase & Signal Transduction ⓘ
p‑TSC2↑, 1,
Transcription & Epigenetics ⓘ
p‑H3↑, 1, tumCV↓, 2,
Autophagy & Lysosomes ⓘ
ATG5↑, 1, BNIP3↑, 1, LC3‑Ⅱ/LC3‑Ⅰ↑, 1, LC3B↑, 1, LC3B-II↑, 2, p62↓, 2, TumAuto↑, 2,
DNA Damage & Repair ⓘ
DNAdam↑, 1, DNMTs↓, 1, NBR2↑, 1, P53↑, 1, p‑P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, CycB/CCNB1↑, 1, cycD1/CCND1↓, 1, cycE/CCNE↑, 1, P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State ⓘ
p‑4E-BP1↓, 1, ALDH↓, 1, BMI1↓, 1, CD24↓, 1, CD44↓, 1, CSCs↓, 1, EMT↓, 1, ERK↓, 1, Gli1↓, 1, HH↓, 1, mTOR↓, 5, p‑mTOR↓, 2, NOTCH↓, 1, Smo↓, 1, STAT↓, 1, TumCG↓, 1, TumCG↑, 1,
Migration ⓘ
CAFs/TAFs↝, 1, E-cadherin↑, 1, FAK↓, 1, MMP2↓, 1, MMP9↓, 2, N-cadherin↓, 1, TumCI↓, 5, TumCMig↓, 5, TumCP↓, 3, TXNIP↓, 1, Vim↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 4, PHDs↑, 1, VEGF↓, 2,
Barriers & Transport ⓘ
GLUT1↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 2, IL1↓, 1, IL6↓, 1, IL8↓, 1, p‑IκB↓, 1, p‑IκB↑, 1, JAK↓, 1, NF-kB↓, 3, p50↓, 1, p65↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose↝, 1, eff↓, 4, selectivity↑, 1,
Clinical Biomarkers ⓘ
IL6↓, 1, LDH↓, 1,
Functional Outcomes ⓘ
AntiCan↓, 1, ChemoSideEff↓, 1, neuroP↑, 1, TumVol↓, 1, TumW↓, 1,
Total Targets: 123
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
CYP2E1↓, 1, Ferroptosis↓, 1, lipid-P↓, 1, lipidDe↓, 1, NRF2↑, 2, ROS↓, 1,
Mitochondria & Bioenergetics ⓘ
OCR↓, 1,
Core Metabolism/Glycolysis ⓘ
ACC↓, 1, p‑ACC↑, 1, ALAT↓, 1, p‑AMPK↑, 4, ECAR↑, 1, FAO↑, 1, glucose↓, 1, Glycolysis↑, 1, HK2↑, 1, LDHA↑, 1, lipoGen↓, 1, PDKs↓, 1, PKM2↑, 1, SIRT1↑, 1, SREBP1↓, 1,
Cell Death ⓘ
Apoptosis↓, 1, BAX↓, 1, Fas↓, 1, Ferroptosis↓, 1, iNOS↓, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑mTOR↓, 1, P70S6K↓, 1,
Migration ⓘ
TGF-β1↓, 1, α-SMA↓, 1,
Angiogenesis & Vasculature ⓘ
NO↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, IL10↑, 1, Inflam↓, 1, PGE2↓, 1,
Clinical Biomarkers ⓘ
ALAT↓, 1, AST↓, 1,
Functional Outcomes ⓘ
cardioP↑, 2, cognitive↑, 1, hepatoP↑, 1, neuroP↑, 2, RenoP↑, 1, toxicity↓, 3,
Total Targets: 44
Scientific Paper Hit Count for: AMPK, adenosine monophosphate-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:9 State#:1 Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page